Annual Meeting – 2012

Join us for the 8th Annual Meeting of the
Oligonucleotide Therapeutics Society!
October 28 – 31, 2012
The Conference Center at Harvard Medical School
Boston, Massachusetts


Join leading experts in the field during this three and a half day meeting featuring the latest developments from various oligonucleotide-based disciplines including antisense, siRNA, immunomodulatory, aptamers and micro/non-coding RNA research.

Click here to register now!


Organizing Chair

Muthiah Manoharan, PhD Alnylam Pharmaceuticals

Scientific Program Committee

Masad Damha, PhD, McGill University
Fritz Eckstein, PhD, Max Planck Institute
Anastasia Khvorova, PhD, Former CSO at RXi and Dharmacon
Ryszard Kole, PhD, AVI BioPharma
Art Krieg, MD, RaNA Therapeutics
Art Levin, PhD, miRagen Therapeutics
Akira Matsuda, PhD, Hokkaido University
Tom Tuschl, PhD, Rockefeller University

Keynote Session

Keynote Speaker

Phillip A. Sharp, PhD Massachusetts Institute
of Technology

Plenary Speakers

John Maraganore, PhD Alnylam Pharmaceuticals

Stanley T. Crooke, MD, PhD Isis Pharmaceuticals

Paul Schimmel, PhD, The Scripps Research Institute

Topics will include all areas of Oligonucleotide Therapeutics covering:

  1. Imparting Drug-like Properties via Chemical Modifications
  2. Structural Biology of Therapeutic Mechanisms
  3. Emerging Delivery Technologies and their ADME Properties
  4. Novel Therapeutic Targets and Bioinformatic Tools
  5. Novel Mechanisms and Technologies
  6. Clinical Development